|
|
|
Insider
Information: |
Uecker Darrin |
Relationship: |
Chief Technology Offic... |
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
148,941 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,579,658 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
148,941 |
|
|
Total
Value |
$2,579,658 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pulse Biosciences, Inc. |
PLSE |
Chief Technology Offic... |
2023-06-12 |
148,941 |
2017-06-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PLSE |
Pulse Biosciences, Inc. |
CEO and President |
|
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
160,974 |
160,974 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
CEO and President |
|
2018-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,168) |
153,981 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
CEO and President |
|
2019-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,321) |
118,046 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
CEO and President |
|
2020-06-15 |
4 |
OE |
$7.01 |
$60,027 |
D/D |
8,563 |
126,609 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
CEO and President |
|
2021-01-25 |
4 |
OE |
$7.01 |
$9,001 |
D/D |
1,284 |
127,893 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
Director |
|
2022-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,365 |
137,376 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
Chief Technology Officer |
|
2023-06-12 |
4 |
OE |
$2.05 |
$15,098 |
D/D |
7,365 |
877,636 |
0 |
- |
|
PLSE |
Pulse Biosciences, Inc. |
Chief Technology Officer |
|
2023-06-12 |
4/A |
OE |
$2.05 |
$15,098 |
D/D |
7,365 |
148,941 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|